We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » University of Oxford Clarifies Trial Dosing Error in COVID-19 Vaccine Co-Developed With AstraZeneca
University of Oxford Clarifies Trial Dosing Error in COVID-19 Vaccine Co-Developed With AstraZeneca
The University of Oxford has attempted to clarify the dosing error it and AstraZeneca (AZ) made in a clinical trial assessing COVID-19 vaccine AZD1222, following divergent reports between the two of what exactly transpired.